Abstract:OBJECTIVE:To explore the correlation of chemokines and chemokine receptors with clinical features of newly diagnosed systemic lupus erythematosus (SLE). METHODS:Samples of venous blood were collected from 37 newly diagnosed SLE patients, 2 males and 35 females, aged 32.5 (15-54), and 20 healthy controls. The serum concentration of macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta and reduced upon activation normal T cell expressed and secreted (RANTES) were measured by ELISA. Samples of anticoagulative serum were collected from 18 of the 37 newly diagnosed SLE patients and 10 healthy controls. The expression rates of CCR1, CCR3, and CCR5 on CD4+ T cells were detected by flow cytometry. Indirect immunofluorescence method was used to detect the anti-ds-DNA antibody, and blot immunoassay was used to detect the anti-RNP and anti-SSA antibodies. The associations of chemokines and chemokine receptors with the clinical features were analyzed. RESULTS:The serum concentration of MIP-1alpha of the SLE patients was (37 +/- 25) ng/L, significantly higher than that of the controls (8 +/- 9) ng/L (P < 0.001). The serum concentration of MIP-1beta of the SLE patients was (160 +/- 140) ng/L, significantly higher than that of the controls (76 +/- 41) ng/L (P = 0.003). The serum concentration of RANTES of the SLE patients was (184 +/- 22) ng/L, not significantly different from that of the controls (144 +/- 79) ng/L (P > 0.05). The serum concentration of MIP-1alpha of the SLE patients with fever was 52 ng/L +/- 27 ng/L, significantly higher than that of the SLE patients without fever (28 ng/L +/- 19 ng/L, P = 0.006). The serum concentration of MIP-1beta of the SLE patients with arthritis was 221 ng/L +/- 158 ng/L, significantly higher than that of the SLE patients without arthritis (95 ng/L +/- 83 ng/L, P = 0.008). The serum concentration of RANTES of the SLE patients with low blood platelet count was 130 ng/L +/- 122 ng/L, significantly lower than that of the SLE patients with normal blood platelet count (212 ng/L +/- 114 ng/L, P = 0.049). The percentage of CD4+ CCR3+ T cell subgroup in CD4+ T cell in peripheral blood of the SLE patients positive in anti-RNP antibody was 14.8% +/- 3.0%, significantly lower than that of the SLE patients negative in anti-RNP antibody (11.3% +/- 2.6%, P = 0.018). CONCLUSION:Abnormality of different chemokines and chemokine receptors may concern with different clinical features of SLE.

Correlation between soluble fractalkine and neuropsychiatric systemic lupus erythematosus

Elevated Levels of Soluble Fractalkine and Increased Expression of CX3CR1 in Neuropsychiatric Systemic Lupus Erythematosus.

Expression of S100B Protein Levels in Serum and Cerebrospinal Fluid with Different Forms of Neuropsychiatric Systemic Lupus Erythematosus.

Surrogate biomarkers identification for neuropsychiatric lupus by proteomic fingerprint technology

Identify Biomarkers of Neuropsychiatric Systemic Lupus Erythematosus by Matrix-assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Combined with Weak Cation Magnetic Beads

Monocyte Chemotactic Protein-1, Fractalkine, and Receptor for Advanced Glycation End Products in Different Pathological Types of Lupus Nephritis and Their Value in Different Treatment Prognoses.

THU0036 Discriminating Central Nervous System Infection and Neuropsychiatric Involvement in Patients with Systemic Lupus Erythematosus: A Single-Center Experience

Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus

Clinical significances of sialylation level in fragment crystaline of serum immunoglobulin G

Correlation between the changes of brain amplitude of low-frequency fluctuation and cognitive impairment in patients with neuropsychiatric lupus

Novel CSF Biomarkers for Diagnosis and Integrated Analysis of Neuropsychiatric Systemic Lupus Erythematosus: Based on Antibody Profiling.

Blood-based biomarkers of neuronal and glial injury in active major neuropsychiatric systemic lupus erythematosus

Levels of Soluble Interleukin-2 Receptor and Clinical Significance in Patients with Systemic Lupus Erythematosus

The role of neuro-associated autoantibodies in neuropsychiatric systemic lupus erythematosus

Correlation of Chemokines and Chemokine Receptors with Clinical Features in Newly Diagnosed Systemic Lupus Erythematosus

Role of IL-1β, IL-6, IL-8 and IFN-γ in pathogenesis of central nervous system neuropsychiatric systemic lupus erythematous.

Brain-Reactive Antibodies Are Potential Biomarkers for Evaluating Therapeutic Efficacy in NPSLE Patients

Cytokine Profiling in Chinese SLE Patients: Correlations with Renal Dysfunction

Investigation of Circulating Fractalkine and its Receptor CX3CR1 Levels in Patients With Chronic Congestive Heart Failure

Predictive factors of psychiatric syndrome in patients with systemic lupus erythematosus

Correlation of chemokines and chemokine receptors with immunological abnormality in newly diagnosed systemic lupus erythemtosus patients